Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2018

01-04-2018

Highlights from the 2017 American Heart Association Scientific Sessions in Anaheim, California

Author: Dylan L. Steen

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2018

Login to get access

Excerpt

The Journal of Thrombosis and Thrombolysis is proud to present the first article in a new section entitled “National and International Meeting Highlights”. Each article in this series will review some of the major studies or guideline updates presented at international conferences. The conferences covered in this series will include the American Heart Association Annual Scientific Sessions, American Society of Hematology Annual Meeting, American College of Cardiology Annual Scientific Session, International Society of Thrombosis and Haemostasis Biennial Congress, and European Society of Cardiology Annual Congress. Although all the exciting presentations at each conference cannot be covered in these articles, we hope this series provides readers with a taste of the ones that may shape guidelines and practice. …
Literature
1.
go back to reference Ridker PM, Thuren ET, MacFadyen JG et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. NEJM 21(12):1119–1131 377)CrossRef Ridker PM, Thuren ET, MacFadyen JG et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. NEJM 21(12):1119–1131 377)CrossRef
4.
go back to reference Mazer CD, Whitlock RP, Fergusson DA et al (2017) Restrictive or liberal red-cell transfusion for cardiac surgery. NEJM 30(22):2133–2144 377)CrossRef Mazer CD, Whitlock RP, Fergusson DA et al (2017) Restrictive or liberal red-cell transfusion for cardiac surgery. NEJM 30(22):2133–2144 377)CrossRef
5.
go back to reference Cannon CP, Bhatt DL, Oldgren J et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. NEJM 19(16):1513–1524 377)CrossRef Cannon CP, Bhatt DL, Oldgren J et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. NEJM 19(16):1513–1524 377)CrossRef
6.
go back to reference Whelton PK, Carey RM, Aronow WS et al (2017) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/AphA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. JACC. https://doi.org/10.1016/j.jacc.2017.11.006 Whelton PK, Carey RM, Aronow WS et al (2017) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/AphA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. JACC. https://​doi.​org/​10.​1016/​j.​jacc.​2017.​11.​006
Metadata
Title
Highlights from the 2017 American Heart Association Scientific Sessions in Anaheim, California
Author
Dylan L. Steen
Publication date
01-04-2018
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2018
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-018-1632-3

Other articles of this Issue 3/2018

Journal of Thrombosis and Thrombolysis 3/2018 Go to the issue